NuvoLase Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Open

NuvoLase General Information

Description

Developer of medical laser technology designed to address the unmet needs of clinicians and patients worldwide. The company's products include a specialized laser system that targets fungal infections located within and beneath the nail plate through the application of light energy without damaging surrounding tissue or skin, enabling medical professionals to use a dedicated tool to improve patient throughput and increase practice revenue while offering individuals a brief in-office procedure for clearer nails.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 10921 Wilshire Boulevard
  • Unit 1011
  • Los Angeles, CA 90024
  • United States
+1 (323)
Primary Industry
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 10921 Wilshire Boulevard
  • Unit 1011
  • Los Angeles, CA 90024
  • United States
+1 (323)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NuvoLase Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Open Market 08-Mar-2021 Completed Generating Revenue
3. Later Stage VC 14-Feb-2017 Completed Generating Revenue
2. Secondary Transaction - Private Completed Startup
1. Early Stage VC 01-Dec-2014 Completed Startup
To view NuvoLase’s complete valuation and funding history, request access »

NuvoLase Patents

NuvoLase Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2229980-A2 Treatment of microbiological pathogens in a toe nail with antimicrobial light Active 16-Mar-2009
EP-2229980-A3 Treatment of microbiological pathogens in a toe nail with antimicrobial light Active 16-Mar-2009
EP-2229980-B1 Treatment of microbiological pathogens in a toe nail with antimicrobial light Inactive 16-Mar-2009
US-20100234925-A1 Treatment of microbiological pathogens in a toe nail with antimicrobial light Inactive 16-Mar-2009 A61N5/0616

NuvoLase Investments & Acquisitions (2)

NuvoLase’s most recent deal was a Merger/Acquisition with PinPointe USA. The deal was made on 13-Sep-2011.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
PinPointe USA 13-Sep-2011 Merger/Acquisition Therapeutic Devices
PathoLase 12-Sep-2011 Buyout/LBO Other Devices and Supplies
To view NuvoLase’s complete investments and acquisitions history, request access »

NuvoLase FAQs

  • When was NuvoLase founded?

    NuvoLase was founded in 2011.

  • Where is NuvoLase headquartered?

    NuvoLase is headquartered in Los Angeles, CA.

  • What industry is NuvoLase in?

    NuvoLase’s primary industry is Other Devices and Supplies.

  • Is NuvoLase a private or public company?

    NuvoLase is a Private company.

  • What is NuvoLase’s current revenue?

    The current revenue for NuvoLase is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process